Tech Company Financing Transactions
Gilead Sciences Funding Round
Gilead Sciences secured a $3 million venture capital round on 3/22/2023. Investors included My Brother's Keeper.
Transaction Overview
Company Name
Announced On
3/22/2023
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Undisclosed
Investors
Proceeds Purpose
These grants will allow organizations to expand their testing programs, provide their communities with access to necessary resources and fight stigma by promoting a culture of compassion and inclusion. It takes more than medicine to end the HIV epidemic and by supporting these organizations, we're increasing their capacity to educate communities, change perceptions and provide critical access to healthcare where it's needed most.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
333 Lakeside Dr.
Foster City, CA 94404
USA
Foster City, CA 94404
USA
Phone
Website
Email Address
Overview
Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel O'Day
Chief Financial Officer
Andrew Dickinson
VP - Bus. Development
Johanna Mercier
VP - General Counsel
Brett Pletcher
VP - Human Resources
Jyoti Mehra
VP - Manufacturing
Taiyin Yang
VP - R & D
William Lee
Browse more venture capital transactions:
Prev: 3/22/2023: Caramel venture capital transaction
Next: 3/23/2023: mbiomics venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on funding rounds that are announced publicly. All VC database entries on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs